Objective: To prepare c(RGDyk) cyclic peptide modified Nano-micelles encapsulating docetaxel (DTX) and to evaluate its ability to reverse the resistance of U87 glioma cells against DTX. Methods: Using Poloxamer 188 (PL-188) as raw material, after carboxylation of succinic anhydride, the c(RGDyk) cyclic peptide was bonded to synthesize c(RGDyk)-PL-188 targeting material and its structure was confirmed by 1H-NMR and FT-IR. c(RGDyk)-PL-188 was used as the coating material; the Nano-micelles encapsulating DTX [c(RGDyk)DTX-NPs] were prepared by Nano coprecipitation method and the prescription was optimized. Transmission electron microscope (TEM), differential scanning calorimetry (DSC) and dynamic dialysis method were used to characterize the morphology, drug crystal form and drug release behavior of c(RGDyk)DTX-NPs in vitro. CCK8 cellular viability assay in vitro, cellular uptake and U87 cells spheroids growth inhibition test were applied to evaluate the reversal effect of c(RGDyk)DTX-NPs on human glioma U87 cells resistance to DTX. Results: 1H-NMR and FT-IR showed that c(RGDyk)-PL-188 was successfully synthesized, which could be spontaneously assembled into micelles with mean particle diameter of (115.6±0.2) nm. When the mass ratio of c(RGDyk)-PL-188/DTX is 10:1, drug loading content and drug loading efficiency for DTX-loaded micelles were high up to 7.88%±0.02% and 85.5%±2.78%, respectively. DTX-loaded micelles had a mean diameter of (159.2±0.2) nm and zeta potential of (-16.8±0.8) mV, exhibiting the spherical shape determined by TEM. In vitro DTX release showed that c(RGDyk)DTX-NPs exhibited sustained-release behavior and the cumulative release of DTX was only 78% within 24 hours. Cellular uptake indicated that c(RGDyk)-NPs could specifically target drug-resistant human glioma U87 cells, which significantly increased the intracellular fluorescence distribution of fluorescent probe ICG, and its targetability was inhibited by free c(RGDyk) solution. Compared with DTX solution and DTX-NPs, c(RGDyk)DTX-NPs had the stronger cytotoxicity to drug-resistant human glioma U87 cells. The study of U87 human glioma cells spheroids model in vitro showed that c(RGDyk)DTX-NPs could penetrate into the deep part of the tumor spheroids more effectively and inhibit the growth of the tumor spheroids. Conclusion: DTX is efficiently encapsulated in c(RGDyk) cyclic peptide modified Nano-micelles with high drug loading content and drug loading efficiency, specifically targeting U87 human glioma cells and reversing their resistance against docetaxel